IRC for solid tumors
| Response designation . | Definition . |
|---|---|
| ir complete remission | Complete disappearance of all lesions (whether measureable or not, and no new lesions), confirmed by a repeat, consecutive assessment no less than 4 weeks from the date first documented |
| ir partial remission | Decrease in tumor burden ≥50% relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation |
| ir stable disease | Not meeting criteria for irCR or irPR, in absence of irPD |
| ir progressive disease | Increase in tumor burden ≥25% relative to nadir (minimum recorded tumor burden), confirmed by a repeat, consecutive assessment no less than 4 weeks from the date first documented |
| Response designation . | Definition . |
|---|---|
| ir complete remission | Complete disappearance of all lesions (whether measureable or not, and no new lesions), confirmed by a repeat, consecutive assessment no less than 4 weeks from the date first documented |
| ir partial remission | Decrease in tumor burden ≥50% relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation |
| ir stable disease | Not meeting criteria for irCR or irPR, in absence of irPD |
| ir progressive disease | Increase in tumor burden ≥25% relative to nadir (minimum recorded tumor burden), confirmed by a repeat, consecutive assessment no less than 4 weeks from the date first documented |
Adapted from Wolchok et al.31 ir, immune response.